Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $28,687 | $13,969 | $16,113 | $12,956 |
| Dep. & Amort. | $6,335 | $5,172 | $4,952 | $4,321 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$6,330 | -$1,227 | -$262 | $4,291 |
| Other Non-Cash | -$9,927 | $274 | -$8,076 | -$2,369 |
| Operating Cash Flow | $18,765 | $18,188 | $12,727 | $19,199 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,627 | -$12,924 | -$7,908 | -$4,193 |
| Net Acquisitions | $0 | -$6,800 | $957 | -$544 |
| Inv. Purchases | -$511 | -$15 | -$5,897 | -$340 |
| Inv. Sales/Matur. | $8,135 | $1,552 | $1,999 | $2,440 |
| Other Inv. Act. | $23,566 | $15,675 | -$13,019 | -$10,423 |
| Investing Cash Flow | $17,563 | -$2,512 | -$23,868 | -$13,060 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,613 | -$70 | -$71 | -$117 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$10,554 | -$9,796 | -$7,694 | -$8,043 |
| Dividends Paid | -$6,519 | -$6,578 | -$6,719 | -$6,839 |
| Other Fin. Act. | -$390 | -$247 | -$203 | -$190 |
| Financing Cash Flow | -$15,850 | -$16,691 | -$14,687 | -$15,189 |
| Forex Effect | $2,936 | $1,957 | $5,005 | $3,944 |
| Net Chg. in Cash | $23,414 | $942 | -$20,823 | -$5,107 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $66,366 | $65,424 | $86,247 | $91,354 |
| End Cash | $89,780 | $66,366 | $65,424 | $86,247 |
| Free Cash Flow | $4,991 | $5,152 | $4,819 | $15,006 |